Skip to main content
CHCT logo

CHCT · Community Healthcare Trust Inc

$18.58 -0.17 (-0.91%)
Market Cap
$535.72M
Shares
28.57M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.75 Open$18.97 Day$18.71–19.08 52W$12.45–19.17 Avg vol 30d207K Short int962K · 3.4% float · 5.1d Short vol58% Last earningsAug 5, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 5

Up next

Next earnings call
Aug 5, 2026 Scheduled · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Bearish Fundamentals Weak Quant / Vol Low
      Market backdrop VIX 20.7 · elevated Equity put/call 0.61
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +13%
      above
      Price vs 50-day avg +5%
      above
      RSI (14) 57
      neutral
      MACD trend Positive
      52-week position 94%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +3%
      trailing
      6-month return +7%
      trailing
      YTD return +17%
      this year
      Relative strength +1%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $18 › 200d $17 — 50d above 200d
      Institutional flow Distributing
      39 of 162 funds reported for Jun 30 · net -25.2K sh shares · +6 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.37% of float · ▲ +27.0% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      162 holders — near 3-yr low, contrarian setup
      Squeeze score 80
      high risk · 0–100
      Fundamentals
      Weak
      Revenue growth +5%
      Y/Y
      EPS growth +135%
      Y/Y
      Valuation P/E 156.3
      rich
      Balance sheet $528.9M
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 25%
      annualized · 1-yr
      Max drawdown −16%
      past year
      ATR 2.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Mar 31, 2021
      Targeted acquisition · go-forward basis $120M – $150M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 3 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +13% Bullish
      Price vs 50-day avg
      +5% Bullish
      RSI (14)
      57 Neutral
      MACD trend
      Positive Bullish
      52-week position
      94% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $18 › 200d $17 — 50d above 200d
      Institutional flow Distributing
      39 of 162 funds reported for Jun 30 · net -25.2K sh shares · +6 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      3.37% of float · ▲ +27.0% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      162 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $12 Now $19 · 94% 52-wk high $19
      vs 200-day avg +13% vs 50-day avg +5%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted funds from operations (AFFO) per diluted common share non-GAAP $0.56 three months ended March 31, 2026
      Funds from operations (FFO) per diluted common share non-GAAP $0.49 three months ended March 31, 2026
      investments in real estate properties 1.2B As of March 31, 2026
      real estate properties 198 As of March 31, 2026
      states with properties 36 As of March 31, 2026
      total square feet of properties 4.5M As of March 31, 2026
      % Leased 90.6% Q4 2025
      Common shares outstanding 28,471,424 Q4 2025
      Debt to Total Capitalization 42.9% Q4 2025
      Dividend yield 11.57% Q4 2025
      Equity market cap $467.5M Q4 2025
      Gross real estate investments $1,216,563K Q4 2025
      Quarter end stock price (per share) $16.42 Q4 2025
      Total square feet owned 4,498,839 Q4 2025
      Weighted average interest rate per annum on Revolving Line of Credit 5.2% Q4 2025
      Weighted average interest rate per annum on Term Loans 4.7% Q4 2025

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CHCT
      Community Healthcare Trust Inc
      this stock
      $535.72M +17.5% +4.7% 156.3 3.4%
      WELL
      Welltower Inc.
      $170.18B +30.3% +35.6% 119.9 2.7%
      VTR
      Ventas, Inc.
      $47.51B +27.1% +18.5% 177.7 5.1%
      DOC
      Healthpeak Properties, Inc.
      $15.50B +42.3% +4.5% 70.3 3.5%
      OHI
      Omega Healthcare Investors Inc
      $15.30B +17.6% +13.2% 18.0 4.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      167
      % held
      75.7%
      Reported
      39 of 162
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      165
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      962.3K
      Days to cover
      5.1d
      Change
      +204.4K sh
      View
      Short Volume
      Short vol %
      58%
      As of
      Jul 29, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      72
      Value
      $1.3K
      As of
      Jul 2, 2026
      View
      Off-Exchange
      Off-exchange %
      47.8%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $121.2M
      Net income (FY)
      $5.1M
      EPS diluted
      $0.08
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      May 7, 2026
      This year
      7
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 5, 2026
      Last call
      May 5, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      CHCT +2.3% +2.6% +6.9% +2.6% +17.5%
      SPY -2.4% -2.3% +6.3% -2.3% +7.0%
      vs SPY +4.7% +4.9% +0.6% +4.9% +10.5%

      Capital returns

      Latest dividend
      $0.48 / share · ex May 11, 2026
      Raised 0.4%
      Paid (TTM)
      $1.906 / share · 4 payouts
      Dividend yield (TTM, derived)
      10.17%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1631569 CUSIP 20369C106 13F (30d) 45 filings 39 filers Visit website Investor relations